VAXIL BIO LTD (VXL.CA) Stock Price, Quote, News and Overview
TSX-V:VXL - TSX Venture Exchange - CA92243L1076 - Common Stock - Currency: CAD
VXL.CA Quote, Performance and Key Statistics
TSX-V:VXL (6/2/2025, 7:00:00 PM)
0.265
+0.04 (+15.22%)
The current stock price of VXL.CA is 0.265 CAD. In the past month the price increased by 2550%. In the past year, price increased by 1225%.
VXL.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 310.73M | ||
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 236.65M | ||
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 192.87M | ||
| TH.CA | THERATECHNOLOGIES INC | N/A | 161.39M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 75.09M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 14.18 | 66.08M | ||
| MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 60.21M | ||
| BLU.CA | BLUENERGIES LTD | N/A | 59.60M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 48.78M | ||
| MBX.CA | MICROBIX BIOSYSTEMS INC | 33 | 46.46M | ||
| SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 44.58M | ||
| ONC.CA | ONCOLYTICS BIOTECH INC | N/A | 40.86M |
Related stock screener links
About VXL.CA
Company Profile
Vaxil Bio Ltd. is an immunotherapy biotech company, which is engaged in the development of immunotherapies such as neoantigen-like peptide products, and antibodies to treat cancer and infectious diseases. The company is headquartered in Toronto, Ontario. The company went IPO on 2011-03-02. The firm is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The firm also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. The company has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. The company exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.
Company Info
VAXIL BIO LTD
3400 One First Canadian Place
TORONTO ONTARIO M5X 1A4 CA
CEO: David Goren
Employees: 0
VAXIL BIO LTD / VXL.CA FAQ
What is the stock price of VAXIL BIO LTD today?
The current stock price of VXL.CA is 0.265 CAD. The price increased by 15.22% in the last trading session.
What is the ticker symbol for VAXIL BIO LTD stock?
The exchange symbol of VAXIL BIO LTD is VXL and it is listed on the TSX Venture Exchange exchange.
On which exchange is VXL.CA stock listed?
VXL.CA stock is listed on the TSX Venture Exchange exchange.
What is VAXIL BIO LTD worth?
VAXIL BIO LTD (VXL.CA) has a market capitalization of 726.10K CAD. This makes VXL.CA a Nano Cap stock.
How many employees does VAXIL BIO LTD have?
VAXIL BIO LTD (VXL.CA) currently has 0 employees.
Should I buy VAXIL BIO LTD (VXL.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of VXL.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of VXL.CA, evaluating the profitability, health, valuation and growth aspects
- VAXIL BIO LTD (VXL.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- VAXIL BIO LTD (VXL.CA) Sales and EPS estimates to see what analysts future expectations are.
- VAXIL BIO LTD (VXL.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- VAXIL BIO LTD (VXL.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- VAXIL BIO LTD (VXL.CA) Stock Chart to make your own analysis
- VAXIL BIO LTD (VXL.CA) Latest news and press-releases to stay up to date.
Does VAXIL BIO LTD (VXL.CA) stock pay dividends?
VXL.CA does not pay a dividend.
What is the Price/Earnings (PE) ratio of VAXIL BIO LTD (VXL.CA)?
VAXIL BIO LTD (VXL.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.04).
VXL.CA Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to VXL.CA. When comparing the yearly performance of all stocks, VXL.CA is one of the better performing stocks in the market, outperforming 99.94% of all stocks.
VXL.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to VXL.CA. No worries on liquidiy or solvency for VXL.CA as it has an excellent financial health rating, but there are worries on the profitability.
VXL.CA Financial Highlights
Over the last trailing twelve months VXL.CA reported a non-GAAP Earnings per Share(EPS) of -0.04. The EPS decreased by -2355.56% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -24.42% | ||
| ROE | -25% | ||
| Debt/Equity | 0 |